Sfoglia per Rivista
Microsatellite analysis in childhood acute lymphoblastic leukemia
1998-01-01 Reato G; Basso G; Putti MC; Cignetti A; Guarini A; Foa R
Il Mieloma multiplo.
1991-01-01 Boccadoro M; Battaglio S; Dianzani U; Frieri R; Gallone G; Massaia M; Omedè P; Palumbo A; Pileri A
MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM
2013-01-01 Ladetto M.; Bruggeman M; Monitillo L.
Minimal residual disease in acute myeloid leukemia detected by Wilms tumor gene 1 expression and multiparameter flow cytometry.
2014-01-01 4. FRAIRIA C., AYDIN S., RIERA L., ALIBERTI S., ALLIONE B, AUDISIO E., D'ARDIA S., DEMURTAS A., FRANCIA DI CELLE P., NICOLINO B., PECORARO C., STACCHINI A., MARMONT M., VITOLO U
Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach?
2017-01-01 Simone, Ferrero; Martin, Dreyling
Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement
2015-01-01 Pigazzi, Martina*; Manara, Elena; Buldini, Barbara; Beqiri, Valzerda; Bisio, Valeria; Tregnago, Claudia; Rondelli, Roberto; Masetti, Riccardo; Caterina Putti, Maria; Fagioli, Franca; Rizzari, Carmelo; Pession, Andrea; Locatelli, Franco; Basso, Giuseppe
Modulation by retinoic acid of the growth of bone marrow cell progenitors from patients with myelodysplastic syndrome.
1989-01-01 DE FRANCESCO A ;SANAVIO F ;STACCHINI A ;PIACIBELLO W ;QUAGLINO D ;AGLIETTA M
MODULATION OF APOPTOSIS
2004-01-01 Saglio G; Morotti A; Cilloni D
Modulation of leukemic cell proliferation by tumor necrosis factor alpha.
1988-01-01 KERIM S ;PIACIBELLO W ;AGLIETTA M
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT
2020-01-01 B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia.
Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology.
2014-01-01 De Rocco D; Bottega R; Cappelli E; Cavani S; Criscuolo M; Nicchia E; Corsolini F; Greco C; Borriello A; Svahn J; Pillon M; Mecucci C; Casazza G; Verzegnassi F; Cugno C; Locasciulli A; Farruggia P; Longoni D; Ramenghi U; Barberi W; Tucci F; Perrotta S; Grammatico P; Hanenberg H; Della Ragione F; Dufour C; Savoia A.
Molecular and clinical studies in hemochromatosis type 2 and 3
2000-01-01 De Gobbi M; Roetto A; Calì A; Daraio F; Barilaro MR; Totaro A; Gasparini P; Cazzola M; Camaschella C
Molecular basis of Diamond-Blackfan anemia: new findings from the Italian registry and a review of the literature
2004-01-01 CAMPAGNOLI MF; GARELLI E; QUARELLO P; CARANDO A; VAROTTO S; NOBILI B; LONGONI D; PECILE V; ZECCA M; DUFOUR C; RAMENGHI U; DIANZANI I
Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia.
1988-01-01 TASSINARI A ;ZACCARIA A ;SAGLIO G ;GUERRASIO A ;TESTONTASSINARI A ;ZACCARIA A ;SAGLIO G ;GUERRASIO A ;TESTONI N ;CELSO B ;ROSTI G ;CAMBRIN GR ;TURA S
Molecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemia.
1991-01-01 ZACCARIA A ;TASSINARI A ;GUERRASIO A ;ROSSO C ;LO COCO F ;DIVERIO D ;TESTONI N ;CELSO B ;BUZZI M ;TURA S
MOLECULAR RELAPSE IN CHRONIC MYELOID LEUKEMIA PATIENTS AFTER IMATINIB DISCONTINUATION: DOES IT ALWAYS NEEDTHERAPY?
2009-01-01 Rege-Cambrin G; Fava C; Ulisciani S; Giugliano E; Gottardi E; Fava M; Giaretto L; Saglio G
Monitoring cytogenetic and molecular response in chronic myeloid leucemia after imatinib mesylate treatment.
2006-01-01 Rege Cambrin G; Giuliano E; Gottardi E.; Fava M.; Fava C.; Mattioli G.; Ulisciani S.; Brunetto V.; Schippa M.;Liberati M.;Saglio G.
Monitoring treatment of chronic myeloid leukemia
2008-01-01 Baccarani M; Pane F; Saglio G.
[Monoclonal gammopathy of uncertain significance]
1984-01-01 BOCCADORO M ;GAVAROTTI P ;PILERI A
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation
2013-01-01 Maffei R; Bulgarelli J; Fiorcari S; Bertoncelli L; Martinelli S; Guarnotta C; Castelli I; Deaglio S; Debbia G; De Biasi S; Bonacorsi G; Zucchini P; Narni F; Tripodo C; Luppi M; Cossarizza A; Marasca R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Microsatellite analysis in childhood acute lymphoblastic leukemia | 1998 | Reato G; Basso G; Putti MC; Cignetti A; Guarini A; Foa R | |
| Il Mieloma multiplo. | 1991 | Boccadoro M; Battaglio S; Dianzani U; Frieri R; Gallone G; Massaia M; Omedè P; Palumbo A; Pileri A | |
| MINIMAL RESIDUAL DISEASE (MRD) DETECTION BY NEXT GENERATION SEQUENCING AND REAL TIME QUANTITATIVE–PCR: A METHODICAL COMPARISON IN ALL, MCL AND MM | 2013 | Ladetto M.; Bruggeman M; Monitillo L. | |
| Minimal residual disease in acute myeloid leukemia detected by Wilms tumor gene 1 expression and multiparameter flow cytometry. | 2014 | 4. FRAIRIA C., AYDIN S., RIERA L., ALIBERTI S., ALLIONE B, AUDISIO E., D'ARDIA S., DEMURTAS A., FRANCIA DI CELLE P., NICOLINO B., PECORARO C., STACCHINI A., MARMONT M., VITOLO U | |
| Minimal residual disease in mantle cell lymphoma: are we ready for a personalized treatment approach? | 2017 | Simone, Ferrero; Martin, Dreyling | |
| Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement | 2015 | Pigazzi, Martina*; Manara, Elena; Buldini, Barbara; Beqiri, Valzerda; Bisio, Valeria; Tregnago, Claudia; Rondelli, Roberto; Masetti, Riccardo; Caterina Putti, Maria; Fagioli, Franca; Rizzari, Carmelo; Pession, Andrea; Locatelli, Franco; Basso, Giuseppe | |
| Modulation by retinoic acid of the growth of bone marrow cell progenitors from patients with myelodysplastic syndrome. | 1989 | DE FRANCESCO A ;SANAVIO F ;STACCHINI A ;PIACIBELLO W ;QUAGLINO D ;AGLIETTA M | |
| MODULATION OF APOPTOSIS | 2004 | Saglio G; Morotti A; Cilloni D | |
| Modulation of leukemic cell proliferation by tumor necrosis factor alpha. | 1988 | KERIM S ;PIACIBELLO W ;AGLIETTA M | |
| MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT | 2020 | B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia. | |
| Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology. | 2014 | De Rocco D; Bottega R; Cappelli E; Cavani S; Criscuolo M; Nicchia E; Corsolini F; Greco C; Borriello A; Svahn J; Pillon M; Mecucci C; Casazza G; Verzegnassi F; Cugno C; Locasciulli A; Farruggia P; Longoni D; Ramenghi U; Barberi W; Tucci F; Perrotta S; Grammatico P; Hanenberg H; Della Ragione F; Dufour C; Savoia A. | |
| Molecular and clinical studies in hemochromatosis type 2 and 3 | 2000 | De Gobbi M; Roetto A; Calì A; Daraio F; Barilaro MR; Totaro A; Gasparini P; Cazzola M; Camaschella C | |
| Molecular basis of Diamond-Blackfan anemia: new findings from the Italian registry and a review of the literature | 2004 | CAMPAGNOLI MF; GARELLI E; QUARELLO P; CARANDO A; VAROTTO S; NOBILI B; LONGONI D; PECILE V; ZECCA M; DUFOUR C; RAMENGHI U; DIANZANI I | |
| Molecular biology studies in Philadelphia chromosome-negative chronic myeloid leukemia. | 1988 | TASSINARI A ;ZACCARIA A ;SAGLIO G ;GUERRASIO A ;TESTONTASSINARI A ;ZACCARIA A ;SAGLIO G ;GUERRASIO A ;TESTONI N ;CELSO B ;ROSTI G ;CAMBRIN GR ;TURA S | |
| Molecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemia. | 1991 | ZACCARIA A ;TASSINARI A ;GUERRASIO A ;ROSSO C ;LO COCO F ;DIVERIO D ;TESTONI N ;CELSO B ;BUZZI M ;TURA S | |
| MOLECULAR RELAPSE IN CHRONIC MYELOID LEUKEMIA PATIENTS AFTER IMATINIB DISCONTINUATION: DOES IT ALWAYS NEEDTHERAPY? | 2009 | Rege-Cambrin G; Fava C; Ulisciani S; Giugliano E; Gottardi E; Fava M; Giaretto L; Saglio G | |
| Monitoring cytogenetic and molecular response in chronic myeloid leucemia after imatinib mesylate treatment. | 2006 | Rege Cambrin G; Giuliano E; Gottardi E.; Fava M.; Fava C.; Mattioli G.; Ulisciani S.; Brunetto V.; Schippa M.;Liberati M.;Saglio G. | |
| Monitoring treatment of chronic myeloid leukemia | 2008 | Baccarani M; Pane F; Saglio G. | |
| [Monoclonal gammopathy of uncertain significance] | 1984 | BOCCADORO M ;GAVAROTTI P ;PILERI A | |
| Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation | 2013 | Maffei R; Bulgarelli J; Fiorcari S; Bertoncelli L; Martinelli S; Guarnotta C; Castelli I; Deaglio S; Debbia G; De Biasi S; Bonacorsi G; Zucchini P; Narni F; Tripodo C; Luppi M; Cossarizza A; Marasca R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile